Clinical Trials Logo

Clinical Trial Summary

Many oral analgesic drugs such as the nonsteroidal anti-inflammatory drug (NSAID) are used to relieve pain from gynaecological procedures and dysmenorrhea. Hyoscine-N-butyl bromide, an antispasmodic drug is commonly used for relief of smooth muscle spasms and can be used to alleviate genito-urinary spasm. Some studies reported hyoscine couldn't relieve pain in minor gynaecological procedures. So the efficacy of Hyoscine-N-butyl bromide use is still controversial, and no previous studies investigated its effectiveness for pain relief in IUD insertion procedure.


Clinical Trial Description

The study objective is to compare the effectiveness and side effects of oral Celecoxib 200mg versus oral hyoscine butyl bromide 10 mg in reducing pain associated with IUD insertion. the study is an attempt to find the most effective drug with the least possible side effects to be used before IUD insertion. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03499743
Study type Interventional
Source Cairo University
Contact
Status Completed
Phase N/A
Start date April 20, 2018
Completion date September 5, 2018

See also
  Status Clinical Trial Phase
Completed NCT04079140 - Vaginal Dinoprostone Administration Prior to Intrauterine Device Insertion Phase 4
Not yet recruiting NCT04301349 - Dinoprostone vs Misoprostol Before LNG-IUD Insertion Phase 3
Recruiting NCT06335823 - Efficacy of Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Reduction During Intrauterine Device (IUD) Insertion in Outpatient Gynecology N/A
Completed NCT04312048 - the Effect of Isosorbide Mononitrate in Reducing Pain During Cooper Intrauterine Device Insertion Phase 3